ECP as prognostic Marker for Melanoma

被引:0
|
作者
Moreira, A. [1 ]
Krueckel, A. [1 ]
Schuler, G. [1 ]
Utikal, J. [2 ]
Heinzerling, L. [1 ]
机构
[1] Univ Klinikum Erlangen, Hautklin, Erlangen, Germany
[2] Univ Med Mannheim, Mannheim, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P08
引用
收藏
页码:27 / 28
页数:2
相关论文
共 50 条
  • [31] CD40 is a prognostic marker in primary cutaneous malignant melanoma
    vandenOord, JJ
    Maes, A
    Stas, M
    Nuyts, J
    Battocchio, S
    Kasran, A
    Garmyn, M
    DeWever, I
    DeWolfPeeters, C
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (06): : 1953 - 1961
  • [32] Is tumor mutational burden a prognostic marker in AJCC stage II melanoma?
    Sinnberg, T.
    Niessner, H.
    Amaral, T.
    Eigentler, T.
    Schroeder, C.
    Lindner, E. S.
    Hilke, F. J.
    Bonzheim, I.
    Fend, F.
    Riess, O.
    Garbe, C.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E29 - E29
  • [33] MMP2 expression is a prognostic marker for primary melanoma patients
    Anand Rotte
    Magdalena Martinka
    Gang Li
    Cellular Oncology, 2012, 35 : 207 - 216
  • [34] CD28-Autoantibodies in Melanoma patients - a new prognostic Marker?
    Schmaltz, R.
    Madjidi, D.
    Preuss, K.-D.
    Mueller, C. S.
    Pfreundschuh, M.
    Graeber, S.
    Vogt, T.
    Pfoehler, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 138 - 138
  • [35] C-MYC oncoprotein: An independent prognostic marker for primary melanoma
    Grover, R
    Ross, DA
    Wilson, GD
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 212 - 212
  • [36] MMP2 expression is a prognostic marker for primary melanoma patients
    Rotte, Anand
    Martinka, Magdalena
    Li, Gang
    CELLULAR ONCOLOGY, 2012, 35 (03) : 207 - 216
  • [37] Sentinel node biopsy in melanoma is not a good prognostic marker for individual patients
    Rees, Jonathan L.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [38] Can PRAME Immunohistochemistry Be Used as a Surrogate Prognostic Marker in Uveal Melanoma?
    Vizcaino, M. Adelita
    Dalvin, Lauren
    Salomao, Diva
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1482 - S1483
  • [39] Is tumor mutational burden a prognostic marker in AJCC stage II melanoma?
    Amaral, Teresa
    Sinnberg, Tobias
    Schroeder, Christopher
    Linder, Elena Sofia
    Niessner, Heike
    Bonzheim, Irina
    Eigentler, Thomas
    Fend, Falko
    Riess, Olaf
    Garbe, Claus
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [40] Is absent c-KIT expression a prognostic marker in cutaneous melanoma?
    Keller, J. Lade
    Riber-Hansen, R.
    Dahl, C.
    Guldberg, P.
    Schmidt, H.
    Hamilton-Dutoit, S. J.
    Steiniche, T.
    VIRCHOWS ARCHIV, 2014, 465 : S14 - S14